Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://harleygeau244277.ivasdesign.com/60128479/trelaglutide-exploring-a-new-treatment-for-chronic-diseases